PMID- 34303196 OWN - NLM STAT- MEDLINE DCOM- 20211117 LR - 20211117 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 571 DP - 2021 Sep 24 TI - Simultaneous monitoring assay for T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface. PG - 53-59 LID - S0006-291X(21)01074-3 [pii] LID - 10.1016/j.bbrc.2021.07.037 [doi] AB - Isolation of antigen (Ag)-specific T cells is an important step in the investigation of T-cell immunity. Activation-induced markers (AIMs), such as CD154/tumor necrosis factor (TNF)/CD107A/CD134/CD137 enable the sorting of Ag-specific T cells without using human leukocyte antigen (HLA)-multimers. However, optimal conditions suitable for simultaneous detection of both Ag-specific CD4 and CD8 T cells have not been investigated. Here, conditions were optimized to simultaneously detect the maximum number of activated CD4 and CD8 T cells in a TCR-dependent manner. First, the frequency of total pools of AIM-positive cells induced by superantigen, staphylococcal enterotoxin B (SEB), stimulation in various culture conditions was monitored and compared side-by-side. The total amount of AIM-positive CD4 T cells, but not CD8 T cells, was significantly abrogated by addition of brefeldin A. TNF-alpha converting enzyme inhibitor treatment effectively increased the TNF-positive population, without affecting other markers' positivity. AIM-positive CD4 T cells and CD8 T cells were detected at least 3 h after stimulation. Furthermore, examination of the multiple combination of each marker revealed that minimum contribution of CD134 on the total pool of AIM-positive cells at this setting, suggesting the essential and non-essential AIMs to maximize the detected number of AIM-positive cells. Taken together, this optimized method will be a useful tool for the simultaneous monitoring the T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface including Ag-specific T cells. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Takahama, Shokichi AU - Takahama S AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. Electronic address: stakahama@nibiohn.go.jp. FAU - Nogimori, Takuto AU - Nogimori T AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. FAU - Higashiguchi, Masaya AU - Higashiguchi M AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. FAU - Murakami, Hirotomo AU - Murakami H AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. FAU - Akita, Hirofumi AU - Akita H AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. FAU - Yamamoto, Takuya AU - Yamamoto T AD - Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. Electronic address: yamamotot2@nibiohn.go.jp. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210721 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Biomarkers) RN - 0 (Receptors, Antigen, T-Cell) SB - IM MH - Biomarkers/metabolism MH - CD4-Positive T-Lymphocytes/*metabolism MH - CD8-Positive T-Lymphocytes/*metabolism MH - Healthy Volunteers MH - Humans MH - Receptors, Antigen, T-Cell/*metabolism MH - Surface Properties OTO - NOTNLM OT - Activation-induced markers OT - Antigen-specific T cells OT - Flow cytometry OT - TCR-Dependent activation EDAT- 2021/07/25 06:00 MHDA- 2021/11/18 06:00 CRDT- 2021/07/24 20:24 PHST- 2021/06/15 00:00 [received] PHST- 2021/07/10 00:00 [accepted] PHST- 2021/07/25 06:00 [pubmed] PHST- 2021/11/18 06:00 [medline] PHST- 2021/07/24 20:24 [entrez] AID - S0006-291X(21)01074-3 [pii] AID - 10.1016/j.bbrc.2021.07.037 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2021 Sep 24;571:53-59. doi: 10.1016/j.bbrc.2021.07.037. Epub 2021 Jul 21.